6 research outputs found

    hERG Potassium Channel Blockage by Scorpion Toxin BmKKx2 Enhances Erythroid Differentiation of Human Leukemia Cells K562

    Get PDF
    <div><p>Background</p><p>The hERG potassium channel can modulate the proliferation of the chronic myelogenous leukemic K562 cells, and its role in the erythroid differentiation of K562 cells still remains unclear.</p> <p>Principal Findings</p><p>The hERG potassium channel blockage by a new 36-residue scorpion toxin BmKKx2, a potent hERG channel blocker with IC<sub>50</sub> of 6.7±1.7 nM, enhanced the erythroid differentiation of K562 cells. The mean values of GPA (CD235a) fluorescence intensity in the group of K562 cells pretreated by the toxin for 24 h and followed by cytosine arabinoside (Ara-C) treatment for 72 h were about 2-fold stronger than those of K562 cells induced by Ara-C alone. Such unique role of hERG potassium channel was also supported by the evidence that the effect of the toxin BmKKx2 on cell differentiation was nullified in hERG-deficient cell lines. During the K562 cell differentiation, BmKKx2 could also suppress the expression of hERG channels at both mRNA and protein levels. Besides the function of differentiation enhancement, BmKKx2 was also found to promote the differentiation-dependent apoptosis during the differentiation process of K562 cells. In addition, the blockage of hERG potassium channel by toxin BmKKx2 was able to decrease the intracellular Ca<sup>2+</sup> concentration during the K562 cell differentiation, providing an insight into the mechanism of hERG potassium channel regulating this cellular process. </p> <p>Conclusions/Significance</p><p>Our results revealed scorpion toxin BmKKx2 could enhance the erythroid differentiation of leukemic K562 cells via inhibiting hERG potassium channel currents. These findings would not only accelerate the functional research of hERG channel in different leukemic cells, but also present the prospects of natural scorpion toxins as anti-leukemic drugs.</p> </div

    Scorpion toxin BmKKx2 primary structure and its pharmacological effect on the hERG channel.

    No full text
    <p>(A) the sequence alignments between scorpion toxins BmKKx2 and BeKm-1 [11,19]. (B) The pharmacological effect of BmKKx2 on hERG channels. The hERG channels were transfected in HEK 293 cells, and their current traces were shown in the absence (control) or presence 10 nM BmKKx2. (C) Dose-dependence curve of BmKKx2 on hERG channels expressed in HEK 293 cells. Symbols and associated error bars represent means ± SD for several cells (n=5). (D) The current trace of hERG potassium channels in absence of BmKKx2 in wild type K562 cells; (E) The pharmacological effect of BmKKx2 on hERG channels in wild type K562 cells. Current traces were shown in the absence (control) or presence 1 μM BmKKx2 .</p

    BmKKx2 binding causing the Ca<sup>2+</sup> concentration decrease during the erythroid differentiation of K562 cells.

    No full text
    <p>(A) Intracellular Ca<sup>2+</sup> was stained by Fluo-8, and the Ca<sup>2+</sup> concentration was measured by flow cytometric analysis. The mean values were mean ± SD from three independent experiments. **<i>p</i><0.01 (Student’s <i>t</i>-test). (B) Flow cytometric analysis of Fluo-8 fluorescence intensity in K562 cells with or without BmKKx2 after Ara-C induced for 24 h.</p

    hERG channel expression suppressed by BmKKx2 in erythroid differentiation of K562 cells.

    No full text
    <p>(A) γ-globin expression in K562 cells during the differentiation with or without BmKKx2 shown by quantitative real-time PCR. (B) hERG channel expression in K562 cells during the differentiation process with or without BmKKx2 shown by quantitative real-time PCR. **<i>p</i><0.01 (Student’s <i>t</i>-test). Symbols and associated error bars represent means ± SD for three independent experiments (C) hERG and γ-globin expression in K562 cells with or without BmKKx2 tested by the western blotting analysis. Both HERG1 and HERG1B isoforms were detected [24]. </p

    Induction of apoptosis by BmKKx2 during the erythroid differentiation of K562 cells.

    No full text
    <p>(A-B) K562 cells were stained with annexin V-FITC and PI and analyzed by flow cytometry. K562 cells were treated with BmKKx2, and BSA was used as the control for 48 h (A). K562 cells were treated with Ara-C (1 μM) and Ara-C (1 μM)+ BmKKx2 for 48 h (B). Flow cytometry data show representative results from one of three independent experiments. (C) Apoptotic cells were stained with annexin V-FITC and PI analyzed by flow cytometry. Values were mean ± SD from three experiments. *<i>p</i><0.05 (Student’s <i>t</i>-test).</p

    No effect of BmKKx2 on the erythroid differentiation in the hERG channel-deficient K562 cells.

    No full text
    <p>(A) hERG channel expression in hERG-silenced and control cells shown by quantitative real-time PCR. (B) hERG channel expression shown by western blotting analysis. HSC70 was used as the endogenous control. (C) BmKKx2 enhancing the differentiation in the lentiviral vector-infected control cells. (D) BmKKx2 with no effect on the differentiation of the hERG-silenced cells. K562 cells in (C) and (D) were treated with Ara-C for 48 h. The right panel of (C) and (D) showed the mean values of GPA fluorescence from three independent samples. **<i>p</i><0.01 (Student’s <i>t</i>-test).</p
    corecore